Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”

DISC1 expression decreases in the course of oligodendrocyte differentiation. by Tsuyoshi Hattori (254566)

Increased proliferation and decreased luminal apoptosis in IGFIR structures by Gina M Yanochko (20949)

TNFα decreased Best-3 expression in endothelium. by Wei Song (30780)

“…(<b>C, D</b>) HUVECs were stimulated with TNFα (10 ng/ml) for different times as indicated. Quantitative PCR (C) and western blot (D) results show a time-dependent decrease of Best-3 expression. …”

Astrocytic AQP4 is decreased in aged cortical astrocytes. by Ileana Soto (531878)

“…<p>(A) AQP4 immunoreactivity (blue) and protein levels (B) are significantly decreased in the aged cortex. …”

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

Iota toxin increases type E adherence while decreases type A adherence. by Leandro M. Redondo (708975)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

IL-15 decreases angiogenesis <i>in vivo</i>. by Krizia Rohena-Rivera (3906838)

ATRA improved vimentin organization and decreased its expression. by Carmen Retana (479628)

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…Notably, miR-155, a known regulator of liver inflammation, had the highest fold increase in cirrhotic livers (2.2-fold, P=4.16E-08) and significantly correlated with hepatic CYP3A activity (r=-0.50, P=0.017). The relative expression (2^-ΔΔCt mean ± SEM) of hepatic CYP3A4 mRNA was significantly higher in cirrhotic livers (21.76 ± 2.65 vs. 5.91 ± 1.29, P=2.04E-07) but their levels did not significantly correlate with hepatic CYP3A activity (r=-0.43, P=0.08).…”

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation. by Jaime Espina (106906)

“…(H) Chart summarizing the morpholino dose-phenotype quantifications of 26 hpf control embryos (n = 71) and injected with 2,5 ng (n = 69), 5 ng (n = 85) or 10 ng (n = 87) of Mocsrnp1a spt morpholino. …”

NS4B decreases TRIF protein level. by Yisha Liang (5244368)

Mean (range) Ag content (ng Ag/cm²) of periphyton collected from all three lakes. by Beth C. Norman (754890)

Inhibition of PKC decreases colony formation of carcinoma cells. by Nataliya Kotelevets (156133)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

Decreased IFNγ production by NK cells in A-<i>Ly49h</i> mice occurs independently of the NKC and H2 and is linked to MCMV susceptibility. by Nassima Fodil (669326)

Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant. by Esther Magdalena Marquez-Lona (4183126)

“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”